Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 5/20 | 0.58 |
| ▸ | FNTB | P49356 | 5/20 | 0.58 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.53 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL302151 | 1.00 | FNTA (0.58) | FNTAFNTBPGGT1BNOD1MAPK1 | |
| SCHEMBL7636751 | 0.98 | FNTA (0.56) | FNTAFNTBPGGT1BNOD1MAPK1 | |
| SCHEMBL7636762 | 0.98 | FNTA (0.56) | FNTAFNTBPGGT1BNOD1MAPK1 | |
| SCHEMBL9830511 | 0.90 | NOD1 (0.60) | FNTAFNTBPGGT1BNOD1MAPK1 | |
| SCHEMBL9830509 | 0.90 | NOD1 (0.60) | FNTAFNTBPGGT1BNOD1MAPK1 | |
| SCHEMBL6136379 | 0.89 | NOD1 (0.68) | FNTAFNTBPGGT1BNOD1MAPK1 | |
| SCHEMBL6136376 | 0.89 | NOD1 (0.68) | FNTAFNTBPGGT1BNOD1MAPK1 | |
| SCHEMBL25264982 | 0.87 | NOD1 (0.70) | FNTAFNTBPGGT1BNOD1MAPK1 | |
| SCHEMBL4741209 | 0.87 | NOD1 (0.70) | FNTAFNTBPGGT1BNOD1MAPK1 | |
| SCHEMBL19388198 | 0.87 | NOD1 (0.70) | FNTAFNTBPGGT1BNOD1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2326724-B1 | PRODUCING METHIONINE WITHOUT N-ACYL-METHIONINE | EVONIK DEGUSSA GMBH (DE) | 2019-05-22 | — | — | EP | claimed |
| JP-2012500622-A | — | — | 2012-01-12 | — | — | JP | claimed |
| EP-2326724-A1 | PRODUCING METHIONINE WITHOUT N-ACYL-METHIONINE | Metabolic Explorer (FR) | 2011-06-01 | — | — | EP | claimed |
| WO-2010020681-A1 | PRODUCING METHIONINE WITHOUT N-ACYL-METHIONINE | METABOLIC EXPLORER (FR) | 2010-02-25 | — | — | WO | claimed |
| US-20100047879-A1 | PRODUCING METHIONINE WITHOUT N-ACYL-METHIONINE | EVONIK OPERATIONS GMBH (DE) | 2010-02-25 | — | — | US | claimed |
| US-4859653-A | Use of compositions of matter containing N-acylates of alpha aminoacids for the treatment of skin | MORELLE JEAN V (FR) | 1989-08-22 | — | — | US | claimed |
| US-20250000948-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | ADOCIA (FR) | 2025-01-02 | — | — | US | disclosed |
| EP-4433093-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | Adocia (FR) | 2024-09-25 | — | — | EP | disclosed |
| CN-118488855-A | Solid composition comprising peptide or protein and acylated amino acid | 阿道恰公司 | 2024-08-13 | — | — | CN | disclosed |
| EP-4299057-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | Adocia (FR) | 2024-01-03 | — | — | EP | disclosed |
| CN-116603073-A | Platelet-loaded small molecule pharmaceutical preparation, and preparation method and application thereof | 上海臻上医药科技有限公司 | 2023-08-18 | — | — | CN | disclosed |
| CN-116173237-A | Pharmaceutical formulation, method for the production thereof, and use thereof | 上海臻上医药科技有限公司 | 2023-05-30 | — | — | CN | disclosed |
| WO-2023084118-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | ADOCIA (FR) | 2023-05-19 | — | — | WO | disclosed |
| EP-1128728-B1 | COMPOSITIONS FOR PROTECTING PLANTS AGAINST OXIDATIVE STRESS | MIL CHRISTOPHE DE (FR) | 2003-12-03 | — | — | EP | disclosed |
| US-6492302-B1 | FATTY ACIDS ACYLATED WITH AMINO ACIDS AND SALIFIED BY BASIC AMINO ACIDS AND METHIONINE; ANTIOXIDANTS AND FREE RADICAL SCAVENGERS; FROST RESISTANCE | MORELLE JEAN (FR) | 2002-12-10 | — | — | US | disclosed |
| WO-2002089572-A1 | NATURAL OR ARTIFICIAL CULTURE SUPPORTS AND PRESERVATION MEDIA FOR CUT FLOWERS ENRICHED WITH ACTIVE SUBSTANCES | MORELLE JEAN (FR) | 2002-11-14 | — | — | WO | disclosed |
| EP-1128728-A1 | COMPOSITIONS FOR PROTECTING PLANTS AGAINST OXIDATIVE STRESS | De Mil, Christophe (FR) | 2001-09-05 | — | — | EP | disclosed |
| WO-1999065304-A1 | COMPOSITIONS FOR PROTECTING PLANTS AGAINST OXIDATIVE STRESS | MORELLE JEAN (FR) | 1999-12-23 | — | — | WO | disclosed |
| US-4241085-A | N-ACYL-METHIONINE | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1980-12-23 | — | — | US | disclosed |
| US-4093740-A | N-ACYL-METHIONINE | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSIER (DT) | 1978-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250000948-A1 | SOLID COMPOSITIONS COMPRISING A PEPTIDE OR A PROTEIN AND AN ACYLATED AMINO ACID | NPPA, BCAT1, ANPEP | FNTA 1292/4885FNTB 2480/4885PGGT1B 2868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.